This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2016-2025.
Company Filing History:
Years Active: 2016-2025
Title: Douglas Braun: Innovator in Pharmaceutical Compounds
Introduction
Douglas Braun is a notable inventor based in Mount Horeb, Wisconsin. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating fungal infections and cancer.
Latest Patents
Braun holds a total of 6 patents. His latest patents include "Turbinmicin compounds, compositions and uses thereof," which details an isolated compound of Formula (I) or IA. This patent also covers turbinomycin compounds of Formula (II) or (IIA), as well as a compound isolated from a bacterial species from the sea squirt, with a chemical formula of CHNO. The compositions described include pharmaceutical formulations that utilize turbinmicin and its derivatives for treating fungal infections, including those caused by drug-resistant strains. Additionally, he has developed methods for treating these infections using turbinmicin and its compounds. Another significant patent is "Biemamides and related scaffolds as inhibitors of transforming growth factor-beta signaling," which provides isolated compounds and methods for inhibiting TGF-β signaling and treating cancers associated with this pathway.
Career Highlights
Douglas Braun is affiliated with the Wisconsin Alumni Research Foundation, where he continues to innovate and contribute to the field of pharmaceutical research. His work has been instrumental in advancing treatments for serious health conditions.
Collaborations
Braun has collaborated with notable colleagues, including Timothy Bugni and Fan Zhang, enhancing the scope and impact of his research.
Conclusion
Douglas Braun's innovative work in pharmaceutical compounds showcases his commitment to addressing critical health challenges. His patents reflect a deep understanding of complex biological processes and a dedication to improving patient outcomes.